학술논문
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Document Type
Article
Author
Source
In Annals of Oncology May 2021 32(5):600-608
Subject
Language
ISSN
0923-7534